| Mr Imad Khdair, MD | |
|
209 W Spring St, Suite 200, Sylacauga, AL 35150-2973 | |
| (256) 245-5241 | |
| (256) 245-0194 |
| Full Name | Mr Imad Khdair |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 42 Years |
| Location | 209 W Spring St, Sylacauga, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093725624 | NPI | - | NPPES |
| 64281983 | Medicaid | KY | |
| 120103 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 28198 (Kentucky) | Primary |
| 207R00000X | Internal Medicine | 30074 (Alabama) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southerncare New Beacon N. Birmingham | Trussville, AL | Hospice |
| Coosa Valley Medical Center | Sylacauga, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Craddock Health Center P C | 9032135504 | 4 |
News Archive
Altheus Therapeutics, Inc., announced completion of dosing in ZA201, a double-blind, active-controlled Phase 2 trial evaluating the efficacy and safety of Zoenasa® Rectal Gel versus mesalamine enema in 120 patients with left-sided ulcerative colitis.
Researchers at Harvard-affiliated Dana-Farber Cancer Institute have pinpointed a crucial gene on which the normal development of the body's entire blood system depends. If the gene is absent, even the most basic blood stem cells cannot be generated. In a mutated form, this gene can cause a rare and devastating form of leukemia.
Two out of three Canadians are not aware of peripheral arterial disease (P.A.D.), a common vascular disease that affects as many as 800,000 Canadians, according to a study published in the Canadian Journal of Cardiology.
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment.
Amway today announced the opening of the first phase of its new $81 million USD nutrition manufacturing facility in Ada, Michigan, USA, near its world headquarters. The 317,000-square-foot facility will house select manufacturing operations for the company's Nutrilite brand of vitamins, minerals and dietary supplements, sold exclusively by Amway Business Owners.
› Verified 2 days ago
| Entity Name | Craddock Health Center P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184669483 PECOS PAC ID: 9032135504 Enrollment ID: O20051024000652 |
News Archive
Altheus Therapeutics, Inc., announced completion of dosing in ZA201, a double-blind, active-controlled Phase 2 trial evaluating the efficacy and safety of Zoenasa® Rectal Gel versus mesalamine enema in 120 patients with left-sided ulcerative colitis.
Researchers at Harvard-affiliated Dana-Farber Cancer Institute have pinpointed a crucial gene on which the normal development of the body's entire blood system depends. If the gene is absent, even the most basic blood stem cells cannot be generated. In a mutated form, this gene can cause a rare and devastating form of leukemia.
Two out of three Canadians are not aware of peripheral arterial disease (P.A.D.), a common vascular disease that affects as many as 800,000 Canadians, according to a study published in the Canadian Journal of Cardiology.
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment.
Amway today announced the opening of the first phase of its new $81 million USD nutrition manufacturing facility in Ada, Michigan, USA, near its world headquarters. The 317,000-square-foot facility will house select manufacturing operations for the company's Nutrilite brand of vitamins, minerals and dietary supplements, sold exclusively by Amway Business Owners.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Imad Khdair, MD 1816 Summit Pl, Birmingham, AL 35243-3141 Ph: () - | Mr Imad Khdair, MD 209 W Spring St, Suite 200, Sylacauga, AL 35150-2973 Ph: (256) 245-5241 |
News Archive
Altheus Therapeutics, Inc., announced completion of dosing in ZA201, a double-blind, active-controlled Phase 2 trial evaluating the efficacy and safety of Zoenasa® Rectal Gel versus mesalamine enema in 120 patients with left-sided ulcerative colitis.
Researchers at Harvard-affiliated Dana-Farber Cancer Institute have pinpointed a crucial gene on which the normal development of the body's entire blood system depends. If the gene is absent, even the most basic blood stem cells cannot be generated. In a mutated form, this gene can cause a rare and devastating form of leukemia.
Two out of three Canadians are not aware of peripheral arterial disease (P.A.D.), a common vascular disease that affects as many as 800,000 Canadians, according to a study published in the Canadian Journal of Cardiology.
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment.
Amway today announced the opening of the first phase of its new $81 million USD nutrition manufacturing facility in Ada, Michigan, USA, near its world headquarters. The 317,000-square-foot facility will house select manufacturing operations for the company's Nutrilite brand of vitamins, minerals and dietary supplements, sold exclusively by Amway Business Owners.
› Verified 2 days ago
Dr. Mohamed Ammar Aldaher, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 W Spring St, Suite 200, Sylacauga, AL 35150 Phone: 256-245-5241 Fax: 256-245-0194 | |
Mr. Walter P Pinson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 W Spring St, Suite 200, Sylacauga, AL 35150 Phone: 256-245-5241 Fax: 256-245-0194 | |
Kendra Q Crews, P.A. Internal Medicine Medicare: Medicare Enrolled Practice Location: 126 S Anniston Ave, Sylacauga, AL 35150 Phone: 256-249-6050 Fax: 256-249-6053 | |
Dr. Jennie S Wheeler, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 W Hickory St, Sylacauga, AL 35150 Phone: 256-401-4000 | |
Ghayas Ali Habach, M.D., M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 291 James Payton Blvd, Sylacauga, AL 35150 Phone: 256-249-0028 Fax: 256-249-0019 | |
Dr. Mahgoub Abdalla Eltoum, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 209 West Spring Street, Suite 200, Sylacauga, AL 35150 Phone: 256-245-5241 Fax: 256-245-0194 |